Filters: Author is Vail, D M [Clear All Filters]
.
1995. Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin.. Clinical cancer research : an official journal of the American Association for Cancer Research. 1(12):1595-601. Abstract
.
1999. The immunotherapeutic potential of activated canine alveolar macrophages and antitumor monoclonal antibodies in metastatic canine melanoma.. Journal of immunotherapy (Hagerstown, Md. : 1997). 22(5):443-53. Abstract
.
1995. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.. Clinical cancer research : an official journal of the American Association for Cancer Research. 1(10):1165-70. Abstract
.
1995. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine for the treatment of feline mammary adenocarcinoma--a multicenter randomized double-blind study.. Cancer biotherapy. 10(2):125-30. Abstract
.
2003. Postoperative radiotherapy and mitoxantrone for anal sac adenocarcinoma in the dog: 15 cases (1991-2001).. Veterinary and comparative oncology. 1(2):94-104. Abstract
.
1995. Response to liposome-encapsulated doxorubicin (TLC D-99) in a dog with myeloma.. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine. 9(6):425-8.
.
2000. Use of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II), a liposomal cisplatin analogue, in cats with oral squamous cell carcinoma.. American journal of veterinary research. 61(7):791-5. Abstract
